Eidos Therapeutics Inc (EIDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | EIDX | AMGN | GILD | VRTX | REGN |
| Company | Eidos Therapeutics Inc | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 127.57 | 337.03 | 84.39 | 477.70 | 1,149.66 |
| High | 128.49 | 338.70 | 84.65 | 483.98 | 1,165.85 |
| Low | 116.83 | 334.61 | 83.43 | 476.27 | 1,148.13 |
| Last | 122.21 | 335.95 | 83.90 | 477.90 | 1,150.19 |
| Change | -6.23 | +3.03 | +0.01 | +3.74 | +11.38 |
| % Change | -4.85% | +0.91% | +0.01% | +0.79% | +1.00% |
| Volume | 335,500 | 1,626,100 | 8,797,900 | 939,800 | 596,600 |
| 20-Day Average Volume | 113,985 | 1,760,680 | 6,694,915 | 987,025 | 420,385 |
| Previous Close | 128.44 | 332.92 | 83.89 | 474.16 | 1,138.81 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 124.59 | 329.59 | 80.07 | 479.86 | 1,165.51 |
| 20-Day Raw Stochastic | 36.63% | 84.75% | 89.62% | 43.50% | 37.72% |
| 20-Day Relative Strength | 56.42% | 57.67% | 71.87% | 49.36% | 52.90% |
| Weighted Alpha | +136.62 | +27.09 | +18.24 | +33.54 | +41.12 |
| Today's Opinion | 88% Buy | 96% Buy | 88% Buy | 40% Buy | 80% Buy |
| Previous Opinion | 100% Buy | 88% Buy | 88% Buy | 40% Buy | 80% Buy |
| Last Month's Opinion | 100% Buy | 88% Buy | 56% Buy | 88% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.40% since 01/15/21 | +1.78% since 09/12/24 | +0.89% since 09/12/24 | -0.16% since 09/12/24 | -1.23% since 09/12/24 |
| Low | 116.83 on 01/25/21 | 327.15 on 09/13/24 | 81.57 on 09/13/24 | 473.75 on 09/18/24 | 1,134.59 on 09/17/24 |
| High | 131.08 on 01/20/21 | 339.00 on 09/18/24 | 84.65 on 09/19/24 | 490.15 on 09/16/24 | 1,170.58 on 09/13/24 |
| 1-Month | |||||
| %Chg | -4.30% since 12/24/20 | +2.43% since 08/19/24 | +12.69% since 08/19/24 | -2.08% since 08/19/24 | -3.90% since 08/19/24 |
| Low | 116.24 on 01/05/21 | 319.00 on 09/06/24 | 74.34 on 08/20/24 | 460.69 on 09/11/24 | 1,113.24 on 09/11/24 |
| High | 132.54 on 01/04/21 | 339.00 on 09/18/24 | 84.89 on 09/12/24 | 500.25 on 08/30/24 | 1,211.20 on 08/27/24 |
| 3-Month | |||||
| %Chg | +66.75% since 10/23/20 | +9.79% since 06/18/24 | +32.86% since 06/18/24 | +2.27% since 06/18/24 | +10.69% since 06/18/24 |
| Low | 69.38 on 10/30/20 | 303.55 on 06/20/24 | 64.86 on 06/20/24 | 458.04 on 08/13/24 | 1,011.67 on 07/03/24 |
| High | 132.54 on 01/04/21 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 510.64 on 08/01/24 | 1,211.20 on 08/27/24 |
| 6-Month | |||||
| %Chg | +178.07% since 07/24/20 | +23.63% since 03/19/24 | +14.29% since 03/19/24 | +15.10% since 03/19/24 | +19.36% since 03/19/24 |
| Low | 38.44 on 07/31/20 | 260.68 on 04/19/24 | 62.07 on 05/31/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 |
| High | 132.54 on 01/04/21 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 510.64 on 08/01/24 | 1,211.20 on 08/27/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 4,750,670 | 178,589,936 | 104,514,608 | 122,358,416 | 125,480,912 |
| Shares Outstanding, K | 38,873 | 536,435 | 1,245,853 | 258,053 | 110,186 |
| Annual Sales | 26,690,000 | 28,190,000,000 | 27,116,000,000 | 9,869,200,000 | 13,117,200,000 |
| Annual Net Income | -37,840,000 | 6,717,000,000 | 5,665,000,000 | 3,619,600,000 | 3,953,600,000 |
| Last Quarter Sales | 130,000 | 8,388,000,000 | 6,954,000,000 | 2,645,600,000 | 3,547,100,000 |
| Last Quarter Net Income | -30,180,000 | 746,000,000 | 1,614,000,000 | -3,593,600,000 | 1,432,300,000 |
| 60-Month Beta | -0.16 | 0.61 | 0.18 | 0.40 | 0.12 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 4.97 on 08/06/24 | 2.01 on 08/08/24 | -12.83 on 08/01/24 | 11.56 on 08/01/24 |
| Latest Earnings Date | 02/24/21 | 10/29/24 | 11/05/24 | 11/04/24 | 11/07/24 |
| Most Recent Dividend | N/A | 2.250 on 08/16/24 | 0.770 on 09/13/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 08/16/24 | 09/13/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 17.89 | 17.67 | 0.00 | 29.85 |